フルテキストURL Mod_Rheumatol_26_5_730.pdf
著者 Sada, Ken-ei| Harigai, Masayoshi| Amano, Koichi| Atsumi, Tatsuya| Fujimoto, Shouichi| Yuzawa, Yukio| Takasaki, Yoshinari| Banno, Shogo| Sugihara, Takahiko| Kobayashi, Masaki| Usui, Joichi| Yamagata, Kunihiro| Homma, Sakae| Dobashi, Hiroaki| Tsuboi, Naotake| Ishizu, Akihiro| Sugiyama, Hitoshi| Okada, Yasunori| Arimura, Yoshihiro| Matsuo, Seiichi| Makino, Hirofumi|
抄録 OBJECTIVE: To compare disease severity classification systems for six-month outcome prediction in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). METHODS: Patients with newly diagnosed AAV from 53 tertiary institutions were enrolled. Six-month remission, overall survival, and end-stage renal disease (ESRD)-free survival were evaluated. RESULTS: According to the European Vasculitis Study Group (EUVAS)-defined disease severity, the 321 enrolled patients were classified as follows: 14, localized; 71, early systemic; 170, generalized; and 66, severe disease. According to the rapidly progressive glomerulonephritis (RPGN) clinical grading system, the patients were divided as follows: 60, grade I; 178, grade II; 66, grade III; and 12, grade IV. According to the Five-Factor Score (FFS) 2009, 103, 109, and 109 patients had ≤1, 2, and ≥3 points, respectively. No significant difference in remission rates was found in any severity classification. The overall and ESRD-free survival rates significantly differed between grades I/II, III, and IV, regardless of renal involvement. Severe disease was a good predictor of six-month overall and ESRD-free survival. The FFS 2009 was useful to predict six-month ESRD-free survival but not overall survival. CONCLUSIONS: The RPGN grading system was more useful to predict six-month overall and ESRD-free survival than the EUVAS-defined severity or FFS 2009.
キーワード Antineutrophil cytoplasmic antibody-associated vasculitis Eosinophilic granulomatosis with polyangiitis Granulomatosis with polyangiitis Inception cohort Microscopic polyangiitis
備考 This is an Accepted Manuscript of an article published by Taylor & Francis Group
発行日 2016-03-11
出版物タイトル Modern Rheumatology
26巻
5号
出版者 Taylor & Francis
開始ページ 730
終了ページ 737
ISSN 1439-7595
NCID AA1157187X
資料タイプ 学術雑誌論文
言語 English
OAI-PMH Set 岡山大学
著作権者 https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
論文のバージョン author
PubMed ID 26873424
DOI 10.3109/14397595.2016.1140274
Web of Sience KeyUT 000393120600018
関連URL https://doi.org/10.3109/14397595.2016.1140274
タイトル(別表記) The perception of chronic kidney disease in a general population in Okayama, Japan : 2015
著者 内田 治仁| 杉山 斉| 宮崎 雅史| 和田 淳| 四方 賢一| 柏原 直樹| 槇野 博史|
抄録  Public education programs about chronic kidney disease (CKD) have been performed in Okayama, Japan for the past 10 years. The present study investigated the perception of CKD in a general population in Okayama. In October and November 2015, a questionnaire survey was distributed by 12 medical centers in five medical districts in Okayama prefecture. A total of 7,022 respondents who underwent their physical checkup at these centers answered the questionnaire. In response to a questionnaire item asking about the respondent's familiarity with the term "CKD," only 4% of the respondents answered "know it well" and 10% answered "unfamiliar." In contrast, in response to a questionnaire item asking about the respondent's familiarity with "chronic kidney disease," 27% answered "know it well" and 38% answered "unfamiliar." The leading avenue by which the respondents learned about CKD/chronic kidney disease was television, followed by newspapers, magazines, and a family doctor or nurse. The leading component which the respondents considered essential for the diagnosis of CKD/chronic kidney disease was proteinuria. A stratified analysis demonstrated a higher recognition of “CKD" or “chronic kidney disease" in the medical districts in northern Okayama prefecture compared to southern Okayama prefecture. These results indicated that the awareness of CKD in Okayama prefecture is still inadequate. Many people did not appear to realize that the term “CKD" represents "chronic kidney disease". Further continuous public education efforts are required to enlighten people about CKD/chronic kidney disease.
キーワード 慢性腎臓病 (chronic kidney disease) CKD 認知度 (perception) 岡山県 (Okayama) 医療圏別 (medical distinct)
備考 短報 (Short Communication)
出版物タイトル 岡山医学会雑誌
発行日 2017-08-01
129巻
2号
出版者 岡山医学会
出版者(別表記) Okayama Medical Association
開始ページ 101
終了ページ 105
ISSN 0030-1558
NCID AN00032489
資料タイプ 学術雑誌論文
関連URL https://doi.org/10.4044/joma.129.101
言語 Japanese
著作権者 Copyright (c) 2017 岡山医学会
論文のバージョン publisher
査読 有り
DOI 10.4044/joma.129.101
Sort Key 6
Eprints Journal Name joma
参考文献 1 ) 日本透析医学会統計調査委員会 : 図説わが国の慢性透析療法の現況 (2014年12月31日現在). 2 ) Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. : Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts : a collaborative meta-analysis. Lancet (2010) 375, 2073-2081. 3 ) National Kidney Foundation : K/DOQI clinical practice guidelines for chronic kidney disease : Evaluation, classification, and stratification. Am J Kidney Dis (2002) 39, S1-266. 4 ) CKD 診療ガイド2012, 日本腎臓学会編, 東京医学社, 東京 (2012). 5 ) エビデンスに基づくCKD 診療ガイドライン2013, 日本腎臓学会編, 東京医学社, 東京 (2013). 6 ) 内田治仁 : 地域医療連携室のかかわりによる腎臓病療養指導の拡がり. 日本腎臓学会誌 (2015) 57, 828-832.
タイトル(別表記) Clinical Research Core Center and Okayama University
著者 槇野 博史|
キーワード オール岡山大学 臨床研究中核病院 橋渡し研究加速ネットワークプログラム事業
備考 特集 臨床研究品質確保体制整備事業 (Feature Article : Project for Securing High Quality Clinical Research)
出版物タイトル 岡山医学会雑誌
発行日 2017-04-03
129巻
1号
出版者 岡山医学会
出版者(別表記) Okayama Medical Association
開始ページ 45
終了ページ 49
ISSN 0030-1558
NCID AN00032489
資料タイプ 一般雑誌記事
オフィシャル URL http://www.okayama-u.ac.jp/user/oma/|
言語 Japanese
著作権者 Copyright (c) 2017 岡山医学会
論文のバージョン publisher
査読 有り
DOI 10.4044/joma.129.45
Sort Key 9
Eprints Journal Name joma
参考文献 1 ) 那須保友 : 特集 臨床研究中核病院から臨床研究中核病院「岡山大学病院」. 岡山医会誌 (2014) 126, 231-235. 2 ) 文部科学省 : 橋渡し研究加速ネットワ-クプログラム. http://www.tr.mext.go.jp/outline.htm (l 平成28年12月閲覧) 3 ) 那須保友 : 特集 臨床研究品質確保体制整備事業 総合診療棟 (Ⅱ期) 新営工事に伴う臨床研究中核病院 (医療法上) に向けた整備について. 岡山医会誌 (2016) 128, 217-220.
著者 Watanabe, Mayu| Nakatsuka, Atsuko| Murakami, Kazutoshi| Inoue, Kentaro| Terami, Takahiro| Higuchi, Chigusa| Katayama, Akihiro| Teshigawara, Sanae| Eguchi, Jun| Ogawa, Daisuke| Watanabe, Eijiro| Wada, Jun| Makino, Hirofumi|
発行日 2014-05-25
出版物タイトル PLOS ONE
9巻
3号
資料タイプ 学術雑誌論文
著者 Ogawa, Daisuke| Eguchi, Jun| Wada, Jun| Terami, Naoto| Hatanaka, Takashi| Tachibana, Hiromi| Nakatsuka, Atsuko| Sato Horiguchi, Chikage| Nishii, Naoko| Makino, Hirofumi|
発行日 2014-01-22
出版物タイトル PLOS ONE
9巻
1号
資料タイプ 学術雑誌論文
著者 Katayama, Akihiro| Nakatsuka, Atsuko| Eguchi, Jun| Murakami, Kazutoshi| Teshigawara, Sanae| Kanzaki, Motoko| Nunoue, Tomokazu| Hida, Kazuyuki| Wada, Nozomu| Yasunaka, Tetsuya| Ikeda, Fusao| Takaki, Akinobu| Yamamoto, Kazuhide| Kiyonari, Hiroshi| Makino, Hirofumi| Wada, Jun|
発行日 2015
出版物タイトル Scientific reports
5巻
資料タイプ 学術雑誌論文
著者 Kitamura, Shinji| Sakurai, Hiroyuki| Makino, Hirofumi|
発行日 2015-03
出版物タイトル Stem cells
33巻
3号
資料タイプ 学術雑誌論文
著者 槇野 博史|
発行日 2015-08-03
出版物タイトル 岡山医学会雑誌
127巻
2号
資料タイプ 一般雑誌記事
JaLCDOI 10.18926/AMO/53117
フルテキストURL 69_1_1.pdf
著者 Watatani, Hiroyuki| Yamasaki, Hiroko| Maeshima, Yohei| Nasu, Tatsuyo| Hinamoto, Norikazu| Ujike, Haruyo| Sugiyama, Hitoshi| Sakai, Yoshiki| Tanabe, Katsuyuki| Makino, Hirofumi|
抄録 Diabetic nephropathy is the most common pathological disorder predisposing patients to end-stage renal disease. Considering the increasing prevalence of type 2 diabetes mellitus worldwide, novel therapeutic approaches are urgently needed. ONO-1301 is a novel sustained-release prostacyclin analog that inhibits thromboxane A2 synthase. Here we examined the therapeutic effects of the intermittent administration of slow-release ONO-1301 (SR-ONO) on diabetic nephropathy in obese type 2 diabetes mice, as well as its direct effects on mesangial cells. The subcutaneous injection of SR-ONO (3mg/kg) every 3 wks did not affect the obesity or hyperglycemia in the db/db obese mice used as a model of type 2 diabetes, but it significantly ameliorated their albuminuria, glomerular hypertrophy, glomerular accumulation of type IV collagen, and monocyte/macrophage infiltration, and also the increase of TGF-β1, α-smooth muscle actin (α-SMA) and MCP-1 compared to vehicle treatment. In cultured mouse mesangial cells, ONO-1301 concentration-dependently suppressed the increases in TGF-β, type IV collagen, α-SMA, MCP-1 and fibronectin induced by high ambient glucose, at least partly through prostacyclin (PGI2) receptor-mediated signaling. Taken together, these results suggest the potential therapeutic efficacy of the intermittent administration of SR-ONO against type 2 diabetic nephropathy, possibly through protective effects on mesangial cells.
キーワード prostacyclin ONO-1301 diabetic nephropathy TGF-β1 diabetes mellitus
Amo Type Original Article
発行日 2015-02
出版物タイトル Acta Medica Okayama
69巻
1号
出版者 Okayama University Medical School
開始ページ 1
終了ページ 15
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
OAI-PMH Set 岡山大学
著作権者 CopyrightⒸ 2015 by Okayama University Medical School
論文のバージョン publisher
査読 有り
Submission Path amo/vol69/iss1/1
PubMed ID 25703166
Web of Sience KeyUT 000349740300001
関連URL http://ousar.lib.okayama-u.ac.jp/metadata/53128
著者 Tsuji, Kenji| Kitamura, Shinji| Makino, Hirofumi|
発行日 2014-04-25
出版物タイトル Biochemical and Biophysical Research Communications
447巻
1号
資料タイプ 学術雑誌論文
著者 Terami, Takahiro| Wada, Jun| Inoue, Kentaro| Nakatsuka, Atsuko| Ogawa, Daisuke| Teshigawara, Sanae| Murakami, Kazutoshi| Katayama, Akihiro| Eguchi, Jun| Makino, Hirofumi|
発行日 2013-10-22
出版物タイトル International Journal of Nephrology and Renovascular Disease
6巻
資料タイプ 学術雑誌論文
著者 Inoue, Kentaro| Wada, Jun| Eguchi, Jun| Nakatsuka, Atsuko| Teshigawara, Sanae| Murakami, Kazutoshi| Ogawa, Daisuke| Terami, Takahiro| Katayama, Akihiro| Tone, Atsuhito| Iseda, Izumi| Hida, Kazuyuki| Yamada, Masao| Ogawa, Tomohisa| Makino, Hirofumi|
発行日 2013-10-15
出版物タイトル PLoS ONE
8巻
10号
資料タイプ 学術雑誌論文
著者 Nakayama, Kazunori| Nakao, Kazushi| Takatori, Yuji| Inoue, Junko| Kojo, Shoichirou| Akagi, Shigeru| Fukushima, Masaki| Wada, Jun| Makino, Hirofumi|
発行日 2013-12-18
出版物タイトル International Journal of Nephrology and Renovascular Disease
7巻
資料タイプ 学術雑誌論文
著者 Terasaka, Tomohiro| Otsuka, Fumio| Tsukamoto, Naoko| Nakamura, Eri| Inagaki, Kenichi| Toma, Kishio| Ogura-Ochi, Kanako| Glidewell-Kenney, Christine| Lawson, Mark A.| Makino, Hirofumi|
発行日 2013-12-05
出版物タイトル Molecular and Cellular Endocrinology
381巻
1-2号
資料タイプ 学術雑誌論文
JaLCDOI 10.18926/AMO/52789
フルテキストURL 68_4_235.pdf
著者 Ono, Tetsuichiro| Shikata, Kenichi| Obika, Mikako| Miyatake, Nobuyuki| Kodera, Ryo| Hirota, Daisyo| Wada, Jun| Kataoka, Hitomi| Ogawa, Daisuke| Makino, Hirofumi|
抄録 The aim of this study was to clarify the factors associated with the remission and/or regression of microalbuminuria in Japanese patients with type 2 diabetes mellitus. We retrospectively analyzed the data of 130 patients with type 2 diabetes mellitus with microalbuminuria for 2-6 years (3.39±1.31 years). Remission was defined as improving from microalbuminuria to normoalbuminuria using the albumin/creatinine ratio (ACR), and regression of microalbuminuria was defined as a decrease in ACR of 50% or more from baseline. Progression of microalbuminuria was defined as progressing from microalbuminuria to overt proteinuria during the follow-up period. Among 130 patients with type 2 diabetes mellitus with microalbuminuria, 57 and 13 patients were defined as having remission and regression, respectively, while 26 patients progressed to overt proteinuria. Sex (female), higher HDL cholesterol and lower HbA1c were determinant factors associated with remission/regression of microalbuminuria by logistic regression analysis. Lower systolic blood pressure (SBP) was also correlated with remission/regression, but not at a significant level. These results suggest that proper control of blood glucose, BP and lipid profiles may be associated with remission and/or regression of type 2 diabetes mellitus with microalbuminuria in clinical practice.
キーワード microalbuminuria type 2 diabetes mellitus remission regression
Amo Type Original Article
発行日 2014-08
出版物タイトル Acta Medica Okayama
68巻
4号
出版者 Okayama University Medical School
開始ページ 235
終了ページ 241
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
OAI-PMH Set 岡山大学
著作権者 CopyrightⒸ 2014 by Okayama University Medical School
論文のバージョン publisher
査読 有り
Submission Path amo/vol68/iss4/5
PubMed ID 25145409
Web of Sience KeyUT 000340687500005
関連URL http://ousar.lib.okayama-u.ac.jp/metadata/52828
JaLCDOI 10.18926/AMO/52788
フルテキストURL 68_4_219.pdf
著者 Hinamoto, Norikazu| Maeshima, Yohei| Saito, Daisuke| Yamasaki, Hiroko| Tanabe, Katsuyuki| Nasu, Tatsuyo| Watatani, Hiroyuki| Ujike, Haruyo| Kinomura, Masaru| Sugiyama, Hitoshi| Sonoda, Hikaru| Kanomata, Naoki| Sato, Yasufumi| Makino, Hirofumi|
抄録 Experimental studies have demonstrated the involvement of angiogenesis-related factors in the progression of chronic kidney disease (CKD). There have so far been no reports investigating the distribution and clinical roles of Vasohibin-1 (VASH-1), a negative feedback regulator of angiogenesis, in CKD. We recruited 54 Japanese CKD patients and 6 patients who had normal renal tissues excised due to localized renal cell carcinoma. We evaluated the correlations between the renal expression level of VASH-1 and the clinical/histological parameters. VASH-1 was observed in renal endothelial/mesangial cells, crescentic lesions and interstitial inflammatory cells. Significant positive correlations were observed between 1) crescent formation and the number of VASH-1+ cells in the glomerulus (r=0.48, p=0.001) or cortex (r=0.64, p<0.0001), 2) interstitial cell infiltration and the number of VASH-1+ cells in the cortex (r=0.34, p=0.02), 3) the glomerular VEGFR-2+ area and the number of VASH-1+ cells in the glomerulus (r=0.44, p=0.01) or medulla (r=0.63, p=0.01). These results suggest that the renal levels of VASH-1 may be affected by local inflammation, crescentic lesions and VEGFR-2.
キーワード chronic kidney disease inflammation Vasohibin-1 VEGF-A VEGFR-2
Amo Type Original Article
発行日 2014-08
出版物タイトル Acta Medica Okayama
68巻
4号
出版者 Okayama University Medical School
開始ページ 219
終了ページ 233
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
OAI-PMH Set 岡山大学
著作権者 CopyrightⒸ 2014 by Okayama University Medical School
論文のバージョン publisher
査読 有り
Submission Path amo/vol68/iss4/4
PubMed ID 25145408
Web of Sience KeyUT 000340687500004
関連URL http://ousar.lib.okayama-u.ac.jp/metadata/52824
著者 Sugiyama, Koichi| Sada, Ken-ei| Kurosawa, Michiko| Wada, Jun| Makino, Hirofumi|
発行日 2013-02
出版物タイトル Clinical and Experimental Nephrology
17巻
1号
資料タイプ 学術雑誌論文
著者 Kagawa, Hidetoshi| Hiromasa, Tsutomu| Hara, Takayuki| Takaki, Ayako| Yamanaka, Ryutaro| Sada, Ken-ei| Makino, Hirofumi|
発行日 2012-10
出版物タイトル Clinical and Experimental Nephrology
16巻
5号
資料タイプ 学術雑誌論文
著者 Kitagawa, Masashi| Sugiyama, Hitoshi| Morinaga, Hiroshi| Inoue, Tatsuyuki| Takiue, Keiichi| Ogawa, Ayu| Yamanari, Toshio| Kikumoto, Yoko| Uchida, Haruhito Adam| Kitamura, Shinji| Maeshima, Yohei| Nakamura, Kazufumi| Ito, Hiroshi| Makino, Hirofumi|
発行日 2013-02-19
出版物タイトル PLoS ONE
8巻
2号
資料タイプ 学術雑誌論文
タイトル(別表記) Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophages
フルテキストURL 126_1.pdf
著者 宮本 聡| 四方 賢一| 宮坂 京子| 岡田 震一| 佐々木 基史| 小寺 亮| 廣田 大昌| 梶谷 展生| 高塚 哲全| 片岡 仁美| 西下 伸吾| 堀口 千景| 船越 顕博| 西森 久和| 内田 治仁| 小川 大輔| 槇野 博史|
キーワード cholecystokinin 糖尿病性腎症 抗炎症作用 腎保護効果
備考 平成24年度岡山医学会賞総合研究奨励賞(結城賞)受賞論文 (The 2012 Okayama Medical Association Award)
出版物タイトル 岡山医学会雑誌
発行日 2014-04-01
126巻
1号
出版者 岡山医学会
出版者(別表記) Okayama Medical Association
開始ページ 1
終了ページ 6
ISSN 0030-1558
NCID AN00032489
資料タイプ 学術雑誌論文
関連URL http://www.okayama-u.ac.jp/user/oma/
言語 Japanese
著作権者 Copyright (c) 2014 岡山医学会
論文のバージョン publisher
査読 有り
DOI 10.4044/joma.126.1
Sort Key 1
Eprints Journal Name joma
参考文献 1) Sugimoto H, Shikata K, Hirata K, Akiyama K, Matsuda M, Kushiro M, Shikata Y, Miyatake N, Miyasaka M, Makino H : Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli : glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes (1997) 46, 2075-2081. 2) Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, Wada J, Shikata Y, Makino H : Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes (2003) 52, 2586-2593. 3) Miyamoto S, Shikata K, Miyasaka K, Okada S, Sasaki M, Kodera R, Hirota D, Kajitani N, Takatsuka T, Kataoka HU, Nishishita S, Sato C, et al. : Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage : anti-inflammatory effect of cholecystokinin. Diabetes (2012) 61, 897-907. 4) Rehfeld JF : Clinical endocrinology and metabolism. Cholecystokinin. Best Pract Res Clin Endocrinol Metab (2004) 18, 569-586. 5) Crawley JN, Corwin RL : Biological actions of cholecystokinin. Peptides (1994) 15, 731-755. 6) Meng AH, Ling YL, Zhang XP, Zhang JL : Anti-inflammatory effect of cholecystokinin and its signal transduction mechanism in endotoxic shock rat. World J Gastroenterol (2002) 8, 712-717. 7) Li S, Ni Z, Cong B, Gao W, Xu S, Wang C, Yao Y, Ma C, Ling Y : CCK-8 inhibits LPS-induced IL-1beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappaB pathway. Shock (2007) 27, 678-686. 8) Lacourse KA, Lay JM, Swanberg LJ, Jenkins C, Samuelson LC : Molecular structure of the mouse CCK-A receptor gene. Biochem Biophys Res Commun (1997) 236, 630-635. 9) de Weerth A, Jonas L, Schade R, Schoneberg T, Wolf G, Pace A, Kirchhoff F, Schulz M, Heinig T, Greten H, von Schrenck T : Gastrin/cholecystokinin type B receptors in the kidney : molecular, pharmacological, functional characterization, and localization. Eur J Clin Invest (1998) 28, 592-601. 10) Xu SJ, Gao WJ, Cong B, Yao YX, Gu ZY : Effect of lipopolysaccharide on expression and characterization of cholecystokinin receptors in rat pulmonary interstitial macrophages. Acta Pharmacol Sin (2004) 25, 1347-1353. 11) Sanchez AP, Sharma K : Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev Mol Med (2009) 11, e13. 12) Takano Y, Yamauchi K, Hayakawa K, Hiramatsu N, Kasai A, Okamura M, Yokouchi M, Shitamura A, Yao J, Kitamura M : Transcriptional suppression of nephrin in podocytes by macrophages : roles of inflammatory cytokines and involvement of the PI3K/Akt pathway. FEBS Lett (2007) 581, 421-426. 13) Leon-Tamariz F, Verbaeys I, Van Boven M, De Cuyper M, Buyse J, de Witte P, Verbruggen A, Cokelaere M : Biodistribution and pharmacokinetics of PEG-10kDa-cholecystokinin-10 in rats after different routes of administration. Curr Drug Deliv (2010) 7, 137-143.